Marley Kayden breaks down Him & Hers (HIMS) after the company missed on both earnings and revenue. She explains how the end of the weight-loss drug shortage hurt their momentum, despite a rise in subscribers. Tim Biggam walks us through how to approach an example options trade for Hims & Hers.